InVivo Therapeutics Appoints Interim CEO, CFO to Replace Francis Reynolds

InVivo Therapeutics Holdings has appointed Michael J. Astrue as interim CEO and Sean Moran as acting CFO in the wake of former CEO and CFO Francis Reynolds resigning his posts due to a medical condition, according to a Hispanic Business report.

Advertisement

Mr. Moran currently serves as the company’s director of finance. Mr. Astrue is the non-executive chairman of the board at Vivus biopharmaceutical company. Both appointments are effective immediately.

InVivo’s board of directors will conduct a search for a permanent CEO throughout the year.

More Articles on Devices:
7 Spine-Focused Device Company Financial Reports
Zimmer PSI Shoulder System Receives FDA 510(k) Clearance
Hoag Memorial Hospital Adopts SECURE-C Cervical Disc Treatment

Advertisement

Next Up in Spinal Tech

  • Zavation Medical has acquired ChoiceSpine, and Derek Kuyper will be CEO of the combined company, according to a Feb. 26…

  • Carlsmed saw significant gains in fourth-quarter and 2025 revenue, according to financial results posted Feb. 25. Five things to know:…

Advertisement

Comments are closed.